Arteriosclerosis and Thrombosis, Vol 12, 146-154, Copyright © 1992 by American Heart Association
ARTICLES |
Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study
D Rouy, PM Laplaud, M Saboureau and E Angles-Cano
Institut National de la Sante et de la Recherche Medicale (INSERM) U. 143, Hopital de Bicetre, France.
Lipoprotein(a) (Lp[a]), a highly atherogenic lipoprotein particle, is the prominent apolipoprotein B-containing lipoprotein in the hedgehog (Laplaud PM et al, J Lipid Res 1988;29:1157-1170). In the present work, we studied the consequences of the structural homology between the specific Lp(a) glycoprotein, apoprotein(a), and plasminogen on the generation of plasmin by fibrin-bound tissue-type plasminogen activator. The activation of plasminogen was initiated by adding either native plasma or Lp(a)-free plasma supplemented with the equivalent of 0.25 mg/ml of either purified Lp(a) or albumin to a surface of fibrin prepared on micortitration plates and to which human tissue-type plasminogen activator was specifically bound. With the Lp(a)-free plasma, an increase in the binding and activation of plasminogen as a function of time was observed. In contrast, in the presence of Lp(a) (i.e., native plasma or the reconstituted system), a significant decrease in the binding of plasmin(ogen) (approximately 60%) was obtained. These data indicate that hedgehog Lp(a) interferes with the binding and activation of plasminogen at the fibrin surface and may thereby behave as a factor regulating the extent of fibrin deposition. These results support our previous data indicating that high levels of Lp(a) may have antifibrinolytic effects in humans (Rouy D et al, Arterioscler Thromb 1991;11:629-638), are in agreement with the observation that Lp(a) is a risk factor for atherosclerotic disease, and provide further support to the view of Lp(a) as a link between atherosclerosis and thrombosis.
This article has been cited by other articles:
 |
|
 |
|
  G. Tsurupa, B. Ho-Tin-Noe, E. Angles-Cano, and L. Medved Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) {alpha}C-domains J. Biol. Chem., September 26, 2003; 278(39): 37154 - 37159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lawn, K. Schwartz, and L. Patthy Convergent evolution of apolipoprotein(a) in primates and hedgehog PNAS, October 28, 1997; 94(22): 11992 - 11997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hegele, W. C. Breckenridge, J. H. Brunt, and P. W. Connelly Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1701 - 1706. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Lawn, N. W. Boonmark, K. Schwartz, G. E. Lindahl, D. P. Wade, C. D. Byrne, K. J. Fong, K. Meer, and L. Patthy The Recurring Evolution of Lipoprotein(a) J. Biol. Chem., October 13, 1995; 270(41): 24004 - 24009. [Abstract] [Full Text] [PDF]
|
|